Possible nizatidine-induced subfulminant hepatic failure.
Subfulminant hepatic failure has not been reported to occur with the histamine-2 receptor antagonists. We report a possible case of nizatidine-induced subfulminant hepatic failure leading to the eventual development of cirrhosis.
Chey
W D
WD
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA.
Kochman
M L
ML
Traber
P G
PG
Appelman
H D
HD
Gumucio
J J
JJ
D000328:Adult; D001706:Biopsy; D006801:Humans; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D017093:Liver Failure / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D016567:Nizatidine / Q000009:adverse effects* / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000188:drug therapy
D016567:Nizatidine